Filter posts

ICYMI: How Other Countries Freeload on U.S. Drug Research -WSJ

Writing for the Wall Street Journal this week, former FDA Associate Commissioner Peter Pitts has …

Beyond the IPO: Reverse Mergers to Tap Public Market Capital

On the opening day of the 2017 BIO CEO & Investor Conference in New York …

Fireside Chat with Dr. Kim of Inovio Pharmaceuticals: Immunotherapies and Vaccines

The first Fireside Chat at the 2017 BIO CEO & Investor Conference was with President …

Curing Cancer: Advancements and What is Yet to Come

  Last month, MIT Technology Review reported “Two Infants Treated with Universal Immune Cells Have …

Best Practices for Communication Between FDA and IND Sponsors During Drug Development

The FDA recently released an online course to provide insights to drug sponsors on communicating …

Vaccine-Preventable Outbreaks on the Rise

Since the fall of 2008, the Council on Foreign Relations has been tracking outbreaks of …

Biopharma Companies Tackle Non-Communicable Diseases

Twenty-two leading biopharmaceutical companies, along with partners such as the World Bank and the Union …

ICYMI: Tom Daschle Proposes Biodefense Role for Mike Pence

Featured in The Hill last week was Tom Daschle – former United States Senate Majority Leader …

Jim Greenwood in The Hill: Congress Needs to Prepare for the Next Pandemic

Europe, Asia, and South Korea have all recently reported rapid outbreaks of Bird Flu. With …

New Study Highlights Tremendous Social Value of Childhood Vaccination

Vaccines are widely recognized as one of the most important advances in medical history. Once-devastating …